Citadel Advisors’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,300
Closed -$41.2K 12651
2025
Q3
$41.2K Sell
25,300
-3,400
-12% -$6.64K ﹤0.01% 12282
2025
Q2
$65.4K Sell
28,700
-47,200
-62% -$78K ﹤0.01% 11631
2025
Q1
$118K Buy
75,900
+48,700
+179% +$98.9K ﹤0.01% 11237
2024
Q4
$63.9K Buy
27,200
+26,400
+3,300% +$89.2K ﹤0.01% 12107
2024
Q3
$2.9K Sell
800
-2,100
-72% -$8.38K ﹤0.01% 13710
2024
Q2
$10.1K Sell
2,900
-4,700
-62% -$20.3K ﹤0.01% 13108
2024
Q1
$48.5K Buy
7,600
+4,300
+130% +$26.8K ﹤0.01% 12200
2023
Q4
$21.3K Buy
+3,300
New +$12.6K ﹤0.01% 12572
2023
Q3
Sell
-7,000
Closed -$16.7K 14269
2023
Q2
$16.7K Sell
7,000
-300
-4% -$712 ﹤0.01% 12887
2023
Q1
$13.4K Buy
7,300
+5,700
+356% +$11.1K ﹤0.01% 13365
2022
Q4
$3.04K Buy
+1,600
New +$4.05K ﹤0.01% 14259
2022
Q1
Sell
-21,400
Closed -$111K 13561
2021
Q4
$111K Sell
21,400
-23,300
-52% -$140K ﹤0.01% 12612
2021
Q3
$293K Buy
+44,700
New +$282K ﹤0.01% 11101

Other funds holding AUTL